Teleflex Incorporated (TFX)

NYQ – Real vaqt narxi. Valyuta: USD

129.86

+2.07 (1.62%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

131.00

+1.14 (0.88%)

Bozordan keyin: Jun 26, 2026, 6:40 PM EDT

09.06.2026

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the four‑year follow‑up data from the First-in-Human BIOMAG™-I Clinical Study (NCT04157153)* presented at the EuroPCR conference in Paris, France by Prof. Jan Torzewski (Klinikverbund Allgäu, Germany). Conducted exclusively across European centers and enrolling 116 patients, the study continues to demonstrate a favorable long‑term safety profile1, with no new cardia.

01.06.2026

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it priced its private offering of $500.0 million aggregate principal amount of 5.875% senior notes due 2032 (the “Notes”) at an issue price of 100.000%. The sale of the Notes is expected to close on June 15, 2026, subject to customary closing conditions. The Notes will be guaranteed by each of Teleflex's existing and future wholly-owned domestic subsidiaries that is a guarantor or other obligor unde.

01.06.2026

TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank

Teleflex's portfolio reset is pressuring results, but a cheaper valuation and divestiture proceeds could reshape its outlook over the next 6-12 months.

01.06.2026

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today the commencement of a private offering of $500.0 million aggregate principal amount of senior notes due 2032 (the “Notes”), subject to market and other conditions. The interest rate and other terms of the Notes will be determined at pricing. The Notes will be guaranteed by each of Teleflex's existing and future wholly-owned domestic subsidiaries that is a guarantor or other obligor under its credit agree.

29.05.2026

Teleflex Divestitures: What Investors Should Watch in 2026

TFX targets $2.03B in divestiture proceeds; FTC review, tariffs and remediation costs put 2026 timing, margins and leverage in play.

21.05.2026

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the Interventional Urology Business Unit has released new clinical data across two major urological congresses, reinforcing the value of the UroLift™ System and Barrigel™ rectal spacer in improving patient-centered outcomes across benign prostatic hyperplasia (BPH) and prostate cancer care. Teleflex Interventional Urology innovations help urologists treat medical ne.

15.05.2026

Teleflex Announces Quarterly Dividend

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 30, 2026, to shareholders of record at the close of business on May 25, 2026. About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the.

Videolar

No Data

There is no data to display

Press-relizlar

09.06.2026

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

01.06.2026

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

01.06.2026

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

21.05.2026

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

Teleflex Incorporated (TFX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Teleflex Incorporated (TFX)

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Teleflex Divestitures: What Investors Should Watch in 2026

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

Teleflex Announces Quarterly Dividend

Videolar

No Data

Press-relizlar

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Teleflex Divestitures: What Investors Should Watch in 2026

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

Teleflex Announces Quarterly Dividend

Videolar

No Data

Press-relizlar

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

Search stocks

Teleflex Incorporated (TFX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Teleflex Incorporated (TFX)

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Teleflex Divestitures: What Investors Should Watch in 2026

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

Teleflex Announces Quarterly Dividend

Videolar

No Data

Press-relizlar

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Teleflex Divestitures: What Investors Should Watch in 2026

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

Teleflex Announces Quarterly Dividend

Videolar

No Data

Press-relizlar

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer